Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
2.020
+0.070 (3.59%)
At close: Jul 2, 2026, 4:00 PM EDT
2.000
-0.020 (-0.99%)
After-hours: Jul 2, 2026, 6:37 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $18.95 million as of July 2, 2026. Its market cap has decreased by -91.92% in one year.
Market Cap
18.95M
Enterprise Value
-5.86M
1-Year Change
-91.92%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $18.95M, a decrease of -88.90%. That is a compound annual growth rate of -83.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 18.95M | -53.02% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 20.73M |
| CEL-SCI | 19.92M |
| SeaStar Medical Holding | 19.78M |
| Lipocine | 19.70M |
| Palatin Technologies | 19.29M |
| AEON Biopharma | 18.81M |
| Pasithea Therapeutics | 18.37M |
| Neuphoria Therapeutics | 18.27M |